Amakem NV

- Country
- ๐ง๐ชBelgium
- Ownership
- Private
- Established
- 2010-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.amakem.com
Clinical Trials
3
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)โข Click on a phase to view related trials
Multiple Dose-parallel-group Study of AMA0076 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension
- Conditions
- Ocular HypertensionEye DiseaseGlaucoma
- Interventions
- Drug: Placebo
- First Posted Date
- 2014-05-13
- Last Posted Date
- 2015-01-21
- Lead Sponsor
- Amakem, NV
- Target Recruit Count
- 103
- Registration Number
- NCT02136940
- Locations
- ๐บ๐ธ
Artesia Clinical - Site 11, Artesia, California, United States
๐บ๐ธInglewood Clinical Site - Site 15, Inglewood, California, United States
๐บ๐ธPetaluma Clinical Site - Site 17, Petaluma, California, United States
A Single Centre Study to Evaluate 3 Ophthalmic Formulations in Healthy Subjects
- Conditions
- GlaucomaOcular HypertensionEye Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2013-12-06
- Last Posted Date
- 2014-05-02
- Lead Sponsor
- Amakem, NV
- Target Recruit Count
- 21
- Registration Number
- NCT02003547
Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma
- Conditions
- GlaucomaOcular HypertensionEye Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2012-09-26
- Last Posted Date
- 2013-07-17
- Lead Sponsor
- Amakem, NV
- Target Recruit Count
- 82
- Registration Number
- NCT01693315
- Locations
- ๐บ๐ธ
Artesia Clinical Site - Site 02, Artesia, California, United States
๐บ๐ธInglewood Clinical Site - Site 03, Inglewood, California, United States
๐บ๐ธPetaluma Clinical Site - Site 05, Petaluma, California, United States